Could short telomeres predict lung disease severity?
NCT ID NCT06885515
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether people with pulmonary fibrosis (a scarring lung disease) have shorter telomeres—the protective caps on the ends of chromosomes. Researchers will measure telomere length in blood samples from 100 Israeli patients and follow their health for two years. The goal is to understand how telomere length relates to disease progression, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could help identify patients with short telomeres who may be at higher risk for worse outcomes, pointing toward more personalized monitoring or treatment approaches.
What could go wrong
This is an observational study, not a treatment trial. It will not directly test any new therapy, and the results may not lead to immediate changes in patient care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY FIBROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Barzilai Medical Center
Ashkelon, Israel
-
Tel Aviv Medical Center
Tel Aviv, Israel